{"log_id": 6453492508241406814, "direction": 0, "words_result_num": 48, "words_result": [{"probability": {"variance": 0.009726, "average": 0.960059, "min": 0.466086}, "location": {"width": 864, "top": 182, "height": 39, "left": 221}, "words": "在与强的松联合用药治疗转移性前列腺癌想者中,进行了一项多西他赛的药代动力学研究。多西他赛被CYP3A4代"}, {"probability": {"variance": 0.008824, "average": 0.961239, "min": 0.526658}, "location": {"width": 763, "top": 212, "height": 38, "left": 186}, "words": "谢,而强的松为已知的CYP3八4诱导剂。未观察到强的松对多西他赛药代动力学有统计学意义的影响"}, {"probability": {"variance": 0.021284, "average": 0.921157, "min": 0.476289}, "location": {"width": 842, "top": 243, "height": 41, "left": 221}, "words": "体内试验的结果显示:在同时给予患者酮康唑与多西他赛时,要小心谨慎。因为二者之间存在相互作用的可能性"}, {"probability": {"variance": 0.027227, "average": 0.903886, "min": 0.382714}, "location": {"width": 867, "top": 275, "height": 41, "left": 222}, "words": "多西他与蛋白酶抑制剂(例如:利托那韦)同时应用时,要加以小心,因为蛋白制剂也是细胞色素P450-3A的抑"}, {"probability": {"variance": 0.003135, "average": 0.971393, "min": 0.859418}, "location": {"width": 89, "top": 307, "height": 22, "left": 186}, "words": "制剂和底物"}, {"probability": {"variance": 0.000106, "average": 0.991739, "min": 0.970025}, "location": {"width": 94, "top": 339, "height": 22, "left": 190}, "words": "【药物过量】"}, {"probability": {"variance": 7.6e-05, "average": 0.994073, "min": 0.966823}, "location": {"width": 247, "top": 365, "height": 27, "left": 184}, "words": "过量使用的已知症状及处置方法"}, {"probability": {"variance": 0.022305, "average": 0.925513, "min": 0.392009}, "location": {"width": 289, "top": 397, "height": 26, "left": 218}, "words": "有两例药物过量报导,1例者接受了"}, {"probability": {"variance": 0.007957, "average": 0.937306, "min": 0.658099}, "location": {"width": 536, "top": 401, "height": 36, "left": 546}, "words": "g/m2.另一例接受了200mg/m21小时静脉输注。两例患者均经历了严重"}, {"probability": {"variance": 0.015078, "average": 0.944571, "min": 0.491779}, "location": {"width": 688, "top": 426, "height": 37, "left": 185}, "words": "的中性粒细胞减少,轻度的衰弱,皮肽反应,和轻度的感觉异常。均得到恢复,未出现意外"}, {"probability": {"variance": 0.005829, "average": 0.965911, "min": 0.677985}, "location": {"width": 867, "top": 458, "height": 41, "left": 217}, "words": "多西他赛过量时,尚无解毒药可用,应将想者移至特殊监护病房内严监测生命体征。过量情况下,可能出现不良"}, {"probability": {"variance": 0.007529, "average": 0.95362, "min": 0.59777}, "location": {"width": 897, "top": 488, "height": 44, "left": 180}, "words": "事件。可预料到的过量主要并发症包括骨髓抑制、外周神经毒性及粘膜炎。发现患者用药过量后应尽快进行GCSF治疗"}, {"probability": {"variance": 0.00022, "average": 0.987688, "min": 0.952404}, "location": {"width": 242, "top": 522, "height": 26, "left": 182}, "words": "如有需要,应采取其他对症治疗"}, {"probability": {"variance": 0.000676, "average": 0.977054, "min": 0.928981}, "location": {"width": 94, "top": 553, "height": 22, "left": 188}, "words": "【药理毒理】"}, {"probability": {"variance": 0, "average": 0.998886, "min": 0.998197}, "location": {"width": 71, "top": 581, "height": 20, "left": 182}, "words": "药理作用"}, {"probability": {"variance": 0.008203, "average": 0.963275, "min": 0.58768}, "location": {"width": 867, "top": 610, "height": 42, "left": 216}, "words": "多西他赛为抗肿瘤药,通过促进小管聚合成稳定的微管井抑制北解聚从而使游离小管的数量显著减少。多西他赛与微"}, {"probability": {"variance": 0.010917, "average": 0.958634, "min": 0.624848}, "location": {"width": 208, "top": 642, "height": 26, "left": 180}, "words": "管的结合不改变原丝的数日"}, {"probability": {"variance": 0.000454, "average": 0.989716, "min": 0.873126}, "location": {"width": 792, "top": 672, "height": 42, "left": 214}, "words": "体外实验表明,多西他赛可以破坏微管网状结构,该结构对处于有丝分裂间期的细胞的功能具有重要作用"}, {"probability": {"variance": 0.005907, "average": 0.964323, "min": 0.6074}, "location": {"width": 872, "top": 703, "height": 45, "left": 210}, "words": "休外实验表明,多西他赛对多种小鼠及人体肿细胞株何细胞毒作用。另外,在克隆形成实验中,对新切除的人体肿"}, {"probability": {"variance": 0.010368, "average": 0.952549, "min": 0.523974}, "location": {"width": 885, "top": 735, "height": 43, "left": 179}, "words": "细胞也有细胞毒作用。多西他赛在细胞内浓度高且涨留时间长。此外,对过度表达P糖蛋白(由多药耐药基因编码)"}, {"probability": {"variance": 0.013555, "average": 0.950085, "min": 0.392879}, "location": {"width": 901, "top": 767, "height": 43, "left": 179}, "words": "的许多肿瘤细胞株具有活性。体内实验中,多西他赛抗瘤谱广,对晚期小鼠和人移植性肿均具有抗肿瘤活性,且与用药"}, {"probability": {"variance": 4e-05, "average": 0.993263, "min": 0.984239}, "location": {"width": 72, "top": 801, "height": 22, "left": 178}, "words": "方案无关"}, {"probability": {"variance": 0.05557, "average": 0.845557, "min": 0.439012}, "location": {"width": 70, "top": 833, "height": 22, "left": 178}, "words": "理研究"}, {"probability": {"variance": 0.000507, "average": 0.985028, "min": 0.946176}, "location": {"width": 72, "top": 865, "height": 21, "left": 176}, "words": "致癌作用"}, {"probability": {"variance": 0.004956, "average": 0.949203, "min": 0.780215}, "location": {"width": 227, "top": 898, "height": 23, "left": 211}, "words": "多西他赛的致癌性未进行研究"}, {"probability": {"variance": 2e-05, "average": 0.995921, "min": 0.990395}, "location": {"width": 89, "top": 928, "height": 22, "left": 175}, "words": "致突变作用"}, {"probability": {"variance": 0.005347, "average": 0.973556, "min": 0.620094}, "location": {"width": 867, "top": 958, "height": 42, "left": 210}, "words": "多西他赛在CHO-K1细胞的体外微核及染色体变实验中,及小鼠体内微核实验中表现出有致突变现象。然而,在"}, {"probability": {"variance": 0.014029, "average": 0.953445, "min": 0.499125}, "location": {"width": 741, "top": 988, "height": 37, "left": 222}, "words": "实验中或在CHIO/ HGPRT因突变实验中没有致突变性。本结果与多西他赛的药理学活性是一致的"}, {"probability": {"variance": 1e-06, "average": 0.998287, "min": 0.997396}, "location": {"width": 72, "top": 1015, "height": 22, "left": 174}, "words": "生殖毒性"}, {"probability": {"variance": 0.0046, "average": 0.967768, "min": 0.668561}, "location": {"width": 869, "top": 1042, "height": 41, "left": 208}, "words": "在大鼠静脉注射多西他赛0.3mg/kg(按体表面积折算,约为临床推荐剂量的150),未见对生育力的损伤,但可引起"}, {"probability": {"variance": 0.002783, "average": 0.976837, "min": 0.762323}, "location": {"width": 905, "top": 1068, "height": 43, "left": 172}, "words": "睾丸重量减轻。该结果与大鼠和犬10个周期(每21天给药1次,连续6个月)的重复给药试验结果有相关性:大鼠和犬"}, {"probability": {"variance": 0.010897, "average": 0.951964, "min": 0.5559}, "location": {"width": 908, "top": 1092, "height": 49, "left": 169}, "words": "静脉注射剂量分别为5mgkg和0.375mgkg时(按体表面积计算,分别约相当干临床推荐剂量的13和1/15),可见丸"}, {"probability": {"variance": 0.025306, "average": 0.936277, "min": 0.35153}, "location": {"width": 479, "top": 1125, "height": 31, "left": 177}, "words": "缩和变性,大鼠在低剂量时增加给药次数也表现出相似的作用"}, {"probability": {"variance": 0.019843, "average": 0.926395, "min": 0.36391}, "location": {"width": 869, "top": 1151, "height": 43, "left": 206}, "words": "怀孕时使用多西他赛可导致胎儿损伤。大鼠和家免在器官形成期分别给予多西赛≥0.3ng/kg/和0.03 mp/kg/LI(按"}, {"probability": {"variance": 0.015896, "average": 0.943214, "min": 0.411755}, "location": {"width": 903, "top": 1179, "height": 41, "left": 172}, "words": "体表面积折算,分别相当于临床日推荐剂量的150和1/300),可见胚胎性和胎仔毒性表现为子宫内死亡、吸收胎增"}, {"probability": {"variance": 0.006004, "average": 0.95376, "min": 0.648145}, "location": {"width": 458, "top": 1207, "height": 30, "left": 171}, "words": "加、胎仔体重减轻和骨化延迟)。以上剂量亦可引起母体毒性"}, {"probability": {"variance": 0.000356, "average": 0.986667, "min": 0.940605}, "location": {"width": 135, "top": 1237, "height": 22, "left": 173}, "words": "对生殖能力的损伤"}, {"probability": {"variance": 0.000425, "average": 0.873749, "min": 0.853131}, "location": {"width": 104, "top": 1220, "height": 43, "left": 816}, "words": "民约"}, {"probability": {"variance": 0.009445, "average": 0.966125, "min": 0.532239}, "location": {"width": 534, "top": 1267, "height": 31, "left": 205}, "words": "啮齿动物毒性实验中的不良反应显示多西他赛可能减弱雄性的生育能力"}, {"probability": {"variance": 2e-06, "average": 0.998699, "min": 0.99703}, "location": {"width": 112, "top": 1294, "height": 22, "left": 175}, "words": "【药代动力学】"}, {"probability": {"variance": 0.014869, "average": 0.946427, "min": 0.468911}, "location": {"width": 864, "top": 1321, "height": 42, "left": 203}, "words": "在I期研究中,对癌症患者进行了剂量为205mgm2的多西他赛药代动力学研究。多两他赛的药代动方学特点与"}, {"probability": {"variance": 0.006323, "average": 0.968873, "min": 0.467152}, "location": {"width": 894, "top": 1354, "height": 41, "left": 172}, "words": "剂量无关、符合三室药代动力学模型,a,β,γ半衰期分别为4分钟、36分钟及H小时。后一时相部分原因是由于药"}, {"probability": {"variance": 0.018183, "average": 0.921275, "min": 0.470779}, "location": {"width": 901, "top": 1386, "height": 44, "left": 167}, "words": "物从周边室相对缓慢地消除。在1小时内静咏输注给予多西他赛100mgn2,平均峰浓度为3.7μg/ml.AUC为4.6hg/ml."}, {"probability": {"variance": 0.013545, "average": 0.943339, "min": 0.409407}, "location": {"width": 901, "top": 1419, "height": 41, "left": 170}, "words": "总休清除率和稳态分布容积分别为2Um2与113L。机体总除率的个体差异约为50%。多西他赛的血浆蛋白结合超"}, {"probability": {"variance": 0.000905, "average": 0.971999, "min": 0.927934}, "location": {"width": 53, "top": 1454, "height": 20, "left": 167}, "words": "过95%"}, {"probability": {"variance": 0.003674, "average": 0.976798, "min": 0.601561}, "location": {"width": 863, "top": 1483, "height": 41, "left": 206}, "words": "多西他赛及其代谢产物主业从粪便排泄。经粪便和尿排出的量分别约占所给剂量的75%和6%,仅有少部分以原型排"}, {"probability": {"variance": 0.006549, "average": 0.956247, "min": 0.560046}, "location": {"width": 894, "top": 1515, "height": 41, "left": 168}, "words": "州。体外研究表明,细胞色素P450-3A同功酶与多西他赛的代谢有关,多西他赛的蛋白结合率超过95%,地塞米松并不"}, {"probability": {"variance": 0.006666, "average": 0.94163, "min": 0.783405}, "location": {"width": 207, "top": 1549, "height": 23, "left": 167}, "words": "影响多西他塞与蛋白的结合"}], "language": 3}